Study of ADI-PEG 20 or Placebo Plus Gem and Doc in Previously Treated Subjects With Leiomyosarcoma (ARGSARC)

RECRUITING

National Taiwan University Hospital, Taipei

RECRUITING

Memorial Sloan Kettering Cancer Center, New York

RECRUITING

Taipei Veterans General Hospital, Taipei

RECRUITING

UPMC Hillman Cancer Center, Pittsburgh

RECRUITING

UPenn (Abramson Cancer Center, Pennsylvania Hospital), Philadelphia

RECRUITING

Duke Cancer Institute, Durham

RECRUITING

Mayo Clinic Florida, Jacksonville

RECRUITING

University of Miami/ Sylvester Comprehensive Cancer Center, Miami

RECRUITING

Moffitt Cancer Center, Tampa

RECRUITING

Ohio State University Wexner Medical Center/ The James Cancer Hospital and Solove Research Institute, Columbus

RECRUITING

University Hospitals Cleveland Medical Center, Cleveland

RECRUITING

Cleveland Clinic, Cleveland

RECRUITING

Indiana University, Indianapolis

RECRUITING

University of Michigan, Ann Arbor

RECRUITING

University of Iowa, Iowa City

RECRUITING

Medical College of Wisconsin/ Froedtert Hospital, Milwaukee

RECRUITING

Mayo Clinic Rochester, Rochester

RECRUITING

Northwestern, Chicago

RECRUITING

Washington University School of Medicine - Siteman Cancer Center, St Louis

RECRUITING

University of Texas MD Anderson Cancer Center, Houston

RECRUITING

University of Colorado Cancer Center/ CU Anschutz Medical Campus, Aurora

RECRUITING

Chang Gung Medical Foundation Kaohsiung, Kaohsiung City

RECRUITING

Mayo Clinic Arizona, Phoenix

RECRUITING

USC Norris comprehensive cancer center, Los Angeles

RECRUITING

UCLA, Santa Monica

RECRUITING

UCSF, San Francisco

RECRUITING

Stanford University Medical Centre, Palo Alto

RECRUITING

Mass General Brigham Cancer Center, Boston

RECRUITING

UHN - Princess Margaret Cancer Center (Ontario), Toronto

RECRUITING

McGill University Health Centre (Quebec), Montreal